P

Peijia Medical Ltd
HKEX:9996

Watchlist Manager
Peijia Medical Ltd
HKEX:9996
Watchlist
Price: 3.77 HKD 0.8% Market Closed
Market Cap: 2.5B HKD
Have any thoughts about
Peijia Medical Ltd?
Write Note

Peijia Medical Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Peijia Medical Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
P
Peijia Medical Ltd
HKEX:9996
Cash from Operating Activities
-ÂĄ583.5m
CAGR 3-Years
-48%
CAGR 5-Years
-72%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Operating Activities
ÂĄ689.1m
CAGR 3-Years
67%
CAGR 5-Years
106%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Operating Activities
ÂĄ1.8B
CAGR 3-Years
9%
CAGR 5-Years
26%
CAGR 10-Years
28%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Operating Activities
ÂĄ14.4B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Operating Activities
ÂĄ1.2B
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Operating Activities
ÂĄ132.5m
CAGR 3-Years
-66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Peijia Medical Ltd
Glance View

Market Cap
2.6B HKD
Industry
Health Care

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

Intrinsic Value
5.13 HKD
Undervaluation 27%
Intrinsic Value
Price
P

See Also

What is Peijia Medical Ltd's Cash from Operating Activities?
Cash from Operating Activities
-583.5m CNY

Based on the financial report for Dec 31, 2023, Peijia Medical Ltd's Cash from Operating Activities amounts to -583.5m CNY.

What is Peijia Medical Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-72%

Over the last year, the Cash from Operating Activities growth was -55%. The average annual Cash from Operating Activities growth rates for Peijia Medical Ltd have been -48% over the past three years , -72% over the past five years .

Back to Top